• Aerium Therapeutics SA en liquidation

    VD
    in liquidation
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-550.1.196.858-9
    Sector: Research and development

    Registered since

    4 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    100'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Aerium Therapeutics SA en liquidation

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Aerium Therapeutics SA en liquidation

    • Aerium Therapeutics SA en liquidation is a Company limited by shares (AG) with its legal headquarters in Lausanne. Aerium Therapeutics SA en liquidation belongs to the industry «Research and development» and is currently in liquidation.
    • The management has 3 active persons registered.
    • The company has last changed their commercial register entry on 12.03.2025, under «Notifications» you will find all changes.
    • The company Aerium Therapeutics SA en liquidation is registered under the UID CHE-134.041.210.
    • Agence mondiale antidopage (AMA), Alps & Mediterranean Group SA, Association Union Mondiale de Kyokushin (UMK) have the same address as Aerium Therapeutics SA en liquidation.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    La société a pour but la recherche et le développement d'agents thérapeutiques et d'outils de diagnostic, notamment dans le domaine des maladies infectieuses. La société peut constituer des succursales et des filiales en Suisse et à l'étranger et participer à d'autres entreprises en Suisse et à l'étranger. La société peut accorder des prêts ou des garanties à des actionnaires ou des tiers si cela favorise ses intérêts. La société peut exercer toutes les activités commerciales et financières en rapport direct avec son but.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Fibexa SA société fiduciaire
    Lausanne 09.05.2023

    Would you like to adjust the auditors? Click here.

    Former auditor (1)
    Name City Since Until
    Fidesma Audit Sàrl
    Genève 23.12.2021 05.04.2023

    Other company names

    Source: SOGC

    Past and translated company names

    • Aerium Therapeutics SA
    • SwissThera SA
    • Prophythera SA
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Aerium Therapeutics SA en liquidation

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250312/2025 - 12.03.2025
    Categories: Liquidation, Change of company name, Change in management

    Publication number: HR02-1006280301, Commercial Registry Office Vaud, (550)

    Aerium Therapeutics SA, à Lausanne, CHE-134.041.210 (FOSC du 09.05.2023, p. 0/1005742101). Selon décision de son assemblée générale du 03.02.2025, la société a prononcé sa dissolution.

    La liquidation est opérée sous la raison de commerce:
    Aerium Therapeutics SA en liquidation par Schärli Elmar, de Hergiswil bei Willisau, à Schmitten (FR), nommé liquidateur avec signature individuelle. Les 4'590'000 actions nominatives de CHF 0.01, privilégiées quant au droit de vote, 2'705'000 actions nominatives de CHF 0.02 et 13'216'343 actions nominatives de CHF 0.02, privilégiées quant au produit de liquidation, ne sont désormais plus restreintes quant à la transmissibilité (art. 685a, al. 3 CO). Stampacchia Otello, Honig Peter, Knight Stephen, Maraganore John, Ossipow Vincent et Powell Michael Frank ne sont plus administrateurs;
    leur signature est radiée. Ramoni Claude, nommé président, et Venkayya Rajeev signent désormais individuellement.

    SOGC 230509/2023 - 09.05.2023
    Categories: Change of auditors

    Publication number: HR02-1005742101, Commercial Registry Office Vaud, (550)

    Aerium Therapeutics SA, à Lausanne, CHE-134.041.210 (FOSC du 06.04.2023, p. 0/1005719535).

    Organe de révision:
    Fibexa SA société fiduciaire (CHE-105.961.597), à Lausanne.

    SOGC 230406/2023 - 06.04.2023
    Categories: Change of auditors

    Publication number: HR02-1005719535, Commercial Registry Office Vaud, (550)

    Aerium Therapeutics SA, à Lausanne, CHE-134.041.210 (FOSC du 15.02.2023, p. 0/1005679310). Fidesma Audit Sàrl (CHE-285.703.335) n'est plus organe de révision.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm